US EditionDyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital - Dyne Therapeutics (NASDAQ:DYN), Hercules Capital (NYSE:HTGC)
Summary by Benzinga
1 Articles
1 Articles
All
Left
Center
1
Right
Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital - Dyne Therapeutics (NASDAQ:DYN), Hercules Capital (NYSE:HTGC)
$100 million funded upfront; additional $175 million tied to milestones provides strategic flexibility through key inflection points - WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced it has entered into a $275 million non-dilutive senior secured term loan f…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
